Co-Diagnostics Corp - CODX Net earnings per share for the last four quarters

CoDx (CODX) - corporate logo

Co-Diagnostics, Inc. (CODX) is protected by CoPrime patents and strict FDA compliance. The rolling annual EPS YoY trend on the GURU.Markets base chart links these barriers to revenues from test system sales, where 33.90 expresses the current value of the metric. Meanwhile, Co-Diagnostics, Inc. (CODX) is combating post-pandemic customer churn by diversifying its diagnostics into veterinary medicine and tuberculosis treatment.

CODX Co-Diagnostics: Net earnings per share (EPS TTM) in the range 02/11/2024 - 11/16/2026

Financial and market metric breakdowns for CoDx (CODX)

- market price and analyst price targets:
Fundamental company valuation:Co-Diagnostics, CODX
Core merchandise of Co-Diagnostics Corp

Against the backdrop of Co-Diagnostics, Inc. (CODX) transforming its business model toward universal IT platforms, the rolling year-over-year (YoY) change in earnings per share allows for an assessment of the company's effectiveness in overcoming the demand crisis for PCR tests. This metric measures the percentage growth in net income over the last 12 months relative to the same period last year, demonstrating to the investor the real dynamics of return on equity amid a structural rebalancing of assets.

Competitor analysis for Co-Diagnostics, Inc.

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) QuidelOrtho Corp QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (caredx.com)|MRVI: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cytek Biosciences, Inc.|Earnings per share for the last twelve months OraSure Technologies (OSUR)|XGN (Exagen) - Earnings per share for the trailing year|Earnings per share for the last twelve months MDxHealth MDXH|LUCD: Earnings per share for the last 12 months|PRE - Earnings per share for the last twelve months|Earnings per share for the trailing year IMDX (Insight Molecular Diagnostics Inc)|TRIB: Net earnings per share (EPS TTM)|prophaselabs.com - Earnings per share for the trailing year|Net earnings per share for the last 12 months AIMD|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)